Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Alterations in Trk A, Trk B and Trk C Receptor Immunoreactivities in Parietal Cortex and Cerebellum in Alzheimer’s Disease

View through CrossRef
The neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 bind to the tyrosine kinase (trk) receptors trk A, trk B and trk C, respectively, with high affinity. We investigated the expression of the trk receptors in the parietal cortex (PC) and cerebellum of patients with Alzheimer’s disease (AD) and age-matched controls. Cortical layers II–VI displayed a distinct cellular immunoreactivity for trk A and C with an emphasis in the pyramidal neurons of layers III and V. Trk B immunoreactivity was primarily located in the deeper cortical layers with a predominance in layer V. There was a decrease in trk A and C immunoreactivity in the PC of AD cases, while trk B density appeared to be unchanged. In addition, cerebellar Purkinje cells revealed a distinct immunoreactivity for trk C both in control and AD cases, suggesting trk C may be important in the maintenance of these cells in the aged brain.
Title: Alterations in Trk A, Trk B and Trk C Receptor Immunoreactivities in Parietal Cortex and Cerebellum in Alzheimer’s Disease
Description:
The neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 bind to the tyrosine kinase (trk) receptors trk A, trk B and trk C, respectively, with high affinity.
We investigated the expression of the trk receptors in the parietal cortex (PC) and cerebellum of patients with Alzheimer’s disease (AD) and age-matched controls.
Cortical layers II–VI displayed a distinct cellular immunoreactivity for trk A and C with an emphasis in the pyramidal neurons of layers III and V.
Trk B immunoreactivity was primarily located in the deeper cortical layers with a predominance in layer V.
There was a decrease in trk A and C immunoreactivity in the PC of AD cases, while trk B density appeared to be unchanged.
In addition, cerebellar Purkinje cells revealed a distinct immunoreactivity for trk C both in control and AD cases, suggesting trk C may be important in the maintenance of these cells in the aged brain.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Widespread Neurotrophin Receptor Expression in the Immune System and Other Nonneuronal Rat Tissues
Widespread Neurotrophin Receptor Expression in the Immune System and Other Nonneuronal Rat Tissues
Abstract: RNase protection analysis using p75, trk A, and trk B RNA probes was used to examine mRNA expression in rat tissues, with particular emphasis on the immune system. Every ...
Abstract C65: TRK kinase domain mutations that induce resistance to a pan-TRK inhibitor
Abstract C65: TRK kinase domain mutations that induce resistance to a pan-TRK inhibitor
Abstract Background: Gene fusions involving members of the NTRK family have been identified in several types of cancer. The use of TRK inhibitors in vitro and in viv...
Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma Cells
Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma Cells
Little is known about the signal transduction pathways of TRK family receptors in neuroblastoma (NB) cells. In this study, an NB cell line, designated MP‐N‐TS, was established from...
Discovery of Bavachin as a Dual Trk-A/Trk-B Agonist via Integrated Computational Screening and Experimental Validation
Discovery of Bavachin as a Dual Trk-A/Trk-B Agonist via Integrated Computational Screening and Experimental Validation
Neurotrophins regulate neuronal survival, differentiation, and synaptic plasticity through activation of tropomyosin receptor kinase (Trk) receptors, and their dysregulation is str...
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
<div>Abstract<p>Members of the tropomyosin receptor kinase (TRK) family are expressed in their constitutively activated forms as a result of a gene fusion that occurs a...
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
Data from Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer
<div>Abstract<p>Members of the tropomyosin receptor kinase (TRK) family are expressed in their constitutively activated forms as a result of a gene fusion that occurs a...

Back to Top